The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Chemotherapy-Induced and/or Radiation Therapy-Induced Oral Mucositis-Complicating the Treatment of Cancer
Open accessAbstract
The term mucositis is coined to describe the adverse effects of radiation and chemotherapy treatments. Mucositis is one of the most common adverse reactions encountered in radiation therapy for head and neck cancers, as well as in chemotherapy, in particular with drugs affecting DNA synthesis (S-phase-specific agents such as fluorouracil, methotrexate, and cytarabine). Mucositis may limit the patient's ability to tolerate chemotherapy or radiation therapy, and nutritional status is compromised. It may drastically affect cancer treatment as well as the patient's quality of life. The incidence and severity of mucositis will vary from patient to patient. It will also vary from treatment to treatment. It is estimated that there is 40% incidence of mucositis in patients treated with standard chemotherapy and this will not only increase with the number of treatment cycles but also with previous episodes. Similarly, patients who undergo bone marrow transplantation and who receive high doses of chemotherapy have a 76% chance of getting mucositis. Patients receiving radiation, in particular to head and neck cancers, have a 30% to 60% chance. The exact pathophysiology of development is not known, but it is thought to be divided into direct and indirect mucositis. Chemotherapy and/or radiation therapy will interfere with the normal turnover of epithelial, cells leading to mucosal injury; subsequently, it can also occur due to indirect invasion of Gram-negative bacteria and fungal species because most of the cancer drugs will cause changes in blood counts. With the advancement in cytology, a more precise mechanism has been established. With this understanding, we can select and target particular mediators responsible for the mucositis. Risk factors such as age, nutritional status, type of malignancy, and oral care during treatment will play important roles in the development of mucositis. Many treatment options are available to prevent and treat this condition, but none of them can completely prevent or treat mucositis. More and more pathological methods are being developed to understand this condition so that better therapeutic regimens can be selected. Emphasis also should be made in assessing the patient's psychologic condition, particular depressive disorders. This is important because treatment with antidepressants will not only contribute in lifting depression but also reduces pain somatization. Although mucositis is rarely life-threatening, it will interfere with treatment of cancer to a great extent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Interventions for treating oral mucositis for patients with cancer receiving treatment
Clarkson, J. E., Worthington, H. V., Furness, S., McCabe, M., Khalid, T., & Meyer, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001973.pub4 · Cited by 674
Antman, K. S., Griffin, J. D., Elias, A., Socinski, M. A., Ryan, L., Cannistra, S. A., Oette, D., Whitley, M., Frei, E., & Schnipper, L. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809083191001 · Cited by 669
Sonis, S. T. (1998) · Oral Oncology · doi:10.1016/s1368-8375(97)00053-5 · Cited by 565
Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
Johnson, J. T., Ferretti, G. A., Nethery, W. J., Valdez, I. H., Fox, P. C., Ng, D., Muscoplat, C. C., & Gallagher, S. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308053290603 · Cited by 484
Development, testing, and application of the oral assessment guide.
Eilers, J., Berger, A. M., & Petersen, M. C. (1988) · PubMed · Cited by 409
Sonis, S. T., Eilers, J. P., Epstein, J. B., LeVeque, F. G., Liggett, W. H., Mulagha, M. T., Peterson, D. E., Rose, A. H., Schubert, M. M., Spijkervet, F. K., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990515)85:10<2103::aid-cncr2>3.0.co;2-0 · Cited by 403
Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment
Kostler, W. J., Hejna, M., Wenzel, C., & Zielinski, C. C. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.5.290 · Cited by 366
Harris, J. R., Lippman, M. E., Veronesi, U., & Willett, W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208063270606 · Cited by 296
Parotid gland function during and following radiotherapy of malignancies in the head and neck
Franzén, L., Funegård, U., Ericson, T., & Henriksson, R. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80076-0 · Cited by 245
Cited by
Current trends and challenges in cancer management and therapy using designer nanomaterials
Navya, P. N., Kaphle, A., Srinivas, S. P., Bhargava, S. K., Rotello, V. M., & Daima, H. K. (2019) · Nano Convergence · doi:10.1186/s40580-019-0193-2 · Cited by 672
Radiation-Induced Oral Mucositis
Maria, O. M., Eliopoulos, N., & Muanza, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00089 · Cited by 455
The growing burden of cancer in India: epidemiology and social context
Mallath, M. K., Taylor, D. G., Badwe, R. A., Rath, G. K., Shanta, V, Pramesh, C. S., Digumarti, R., Sebastian, P., Borthakur, B. B., Kalwar, A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70115-9 · Cited by 447
Gastrointestinal toxicity of immune checkpoint inhibitors: From mechanisms to management
Samaan, M. A., Pavlidis, P., Papa, S., Powell, N., & Irving, P. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.14 · Cited by 100
Metadata
- Authors
- Naidu, M. U. R., Ramana, G. V., Rani, P. U., Mohan, L. K., Suman, A., & Roy, P.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 6
- Issue
- 5
- Pages
- 423-431
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W2067222562
- Cited by
- 471
- References
- 26
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemotherapy-Induced and/or Radiation Therapy-Induced Oral Mucositis-Complicating the Treatment of Cancer. https://app.cochat.ai/papers/10.1593/neo.04169
- The paper
- Naidu, M. U. R., Ramana, G. V., Rani, P. U., Mohan, L. K., Suman, A., & Roy, P. (2004). Chemotherapy-Induced and/or Radiation Therapy-Induced Oral Mucositis-Complicating the Treatment of Cancer. Neoplasia. https://doi.org/10.1593/neo.04169
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.